The genie of mRNA gene therapy injections is out of the bottle. Moderna's new shot targets the common cold RSV, an extremely low-risk virus, and the FDA has granted fast-track designation for rapid approval.
This premium content is for premium members only - Check it out! Join Now
Patrick Wood is a leading and critical expert on Sustainable Development, Green Economy, Agenda 21, 2030 Agenda and historic Technocracy. He is the author of Technocracy Rising: The Trojan Horse of Global Transformation (2015) and co-author of Trilaterals Over Washington, Volumes I and II (1978-1980) with the late Antony C. Sutton.
